US FDA approves over-the-counter sale of overdose reversal drug Narcan
Healthcare,Public Health,Opioid Crisis,FDA,Fentanyl
From the Center
AllSides Media Bias Rating: Center
The U.S. Food and Drug Administration on Wednesday approved over-the-counter (OTC) sales of Emergent BioSolutions Inc's (EBS.N) Narcan, allowing for easier availability of the life-saving medication used to reverse opioid overdoses.
The formal decision makes Narcan the first naloxone-based drug available without a prescription.
Emergent said it will make Narcan available on U.S. store shelves and online retailers by late summer.
"I think it's a big win. The question now remains about the cost," said Noa Krawczyk, assistant professor at the NYU Grossman School of Medicine.
The contract drugmaker declined to share details on the price of its OTC version of Narcan.
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
.png.webp)
